Slanix Paul Alex, Director of ProMIS Neurosciences PMN, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $8.5M. The latest trade was on 05/20.

SA

SA

Slanix Paul Alex

Director

Company

ProMIS Neurosciences PMN

First filing

25/10/24

Trades

5 trades

Buys / sales

1 / 0

12-month net buying

$8.5M

Last trade

05/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ProMIS NeurosciencesPMN	Open-market buy	02/03	02/05	700,741 sh	$12.13	$8,499,988.33	+289.1%